Forschungszentrum Translationale Neurowissenschaften (FTN)
Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz
Bellmann-Strobl, Judith; Paul, Friedemann; Wuerfel, Jens et al.
Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis A Randomized, Placebo-Controlled TrialNEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. Bd. 8. H. 3. 2021
Joisten, Niklas; Rademacher, Annette; Warnke, Clemens et al.
Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple SclerosisNEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. Bd. 8. H. 3. 2021
Fu, Ting; Arnoux, Isabelle; Doering, Jan et al.
Exploring two-photon optogenetics beyond 1100 nm for specific and effective all-optical physiologyISCIENCE. Bd. 24. H. 3. 2021
Pfenninger, Markus; Reuss, Friederike; Kiebler, Angelika et al.
Genomic basis for drought resistance in European beech forests threatened by climate changeELIFE. Bd. 10. 2021
Schneider-Hohendorf, Tilman; Schulte-Mecklenbeck, Andreas; Ostkamp, Patrick et al.
High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patientsMULTIPLE SCLEROSIS JOURNAL. Bd. 27. H. 10. 2021 S. 1491-1496
Kaare, Maria; Mikheim, Kaie; Lillevali, Kersti et al.
High-Fat Diet Induces Pre-Diabetes and Distinct Sex-Specific Metabolic Alterations in Negr1-Deficient MiceBIOMEDICINES. Bd. 9. H. 9. 2021
Freudenberg, Florian; Candemir, Esin; Chen, Xufeng et al.
Hippocampal overexpression of NOS1AP promotes endophenotypes related to mental disordersEBIOMEDICINE. Bd. 71. 2021
Regen, Tommy; Isaac, Sandrine; Amorim, Ana et al.
IL-17 controls central nervous system autoimmunity through the intestinal microbiomeSCIENCE IMMUNOLOGY. Bd. 6. H. 56. 2021
Moos, S.; Mohebiany, A. N.; Waisman, A. et al.
Imiquimod-induced psoriasis-like dermatitis in mice depends on IL-17 signaling of keratinocytesEXPERIMENTAL DERMATOLOGY. Bd. 30. H. 3. 2021 S. E20-E20
Engel, Sinah; Protopapa, Maria; Steffen, Falk et al.
Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosisTHERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. Bd. 14. 2021